Meet the Board: Martin Röcken
21 October 2020
The latest instalment of our "Meet the Board" series is from Martin Röcken. Martin joined the ILDS Board in 2019 as an International Director and serves as the Chair of the WCD Scientific Programme Committee.
I am the Professor and Chairman of a large dermatology department, with a strong focus on clinical, experimental and translational oncology. My lab, supported by public funds, characterized major signals allowing the antigen-specific induction of either TH1 or TH2 cells in vivo, first in mice and then in humans, and established immune-based therapies.
The Röcken laboratory explores primarily the role of adaptive immunity, especially of various T cell phenotypes in inflammation, infections and cancer diseases. For this, the lab especially analyzes basic mechanisms of T cell immunology, T cell differentiation, cancer biology and the interactions between the immune system and cancer.
In 2019, I became an International Director of the ILDS. Directly thereafter, I was elected by the ILDS Board as Chair of the Scientific Programme Committee the next World Congress of Dermatology (WCD) in Singapore in 2023. For me, this is an honor and a major task for the upcoming years.
Personally, I consider the ILDS as the organiation that globally furthers dermatology and training in dermatology to provide the best help to individuals with skin diseases in all parts of the world.
The 25th World Congress of Dermatology should serve as an important step towards the realisation of “Global Dermatology”; searching for the most important topics and the best speakers from all five continents. The goals are for a vivid exchange on the different diseases and disease manifestations, the medical needs and a solid training in the most recent developments in diagnosis and therapy.